Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001317
Filing Date
2025-02-21
Accepted
2025-02-21 16:36:59
Documents
107
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptgx-20241231x10k.htm   iXBRL 10-K 2711549
2 EX-4.2 ptgx-20241231xex4d2.htm EX-4.2 19625
3 EX-10.28 ptgx-20241231xex10d28.htm EX-10.28 57663
4 EX-19.1 ptgx-20241231xex19d1.htm EX-19.1 386011
5 EX-21.1 ptgx-20241231xex21d1.htm EX-21.1 3380
6 EX-23.1 ptgx-20241231xex23d1.htm EX-23.1 6302
7 EX-31.1 ptgx-20241231xex31d1.htm EX-31.1 11286
8 EX-31.2 ptgx-20241231xex31d2.htm EX-31.2 11517
9 EX-32.1 ptgx-20241231xex32d1.htm EX-32.1 10722
10 GRAPHIC ptgx-20241231x10k006.jpg GRAPHIC 131276
11 GRAPHIC ptgx-20241231x10k007.jpg GRAPHIC 76044
12 GRAPHIC ptgx-20241231x10k008.jpg GRAPHIC 101736
13 GRAPHIC ptgx-20241231x10k009.jpg GRAPHIC 86544
14 GRAPHIC ptgx-20241231x10k010.jpg GRAPHIC 80105
15 GRAPHIC ptgx-20241231x10k011.jpg GRAPHIC 68977
16 GRAPHIC ptgx-20241231xex19d1001.jpg GRAPHIC 18327
17 GRAPHIC ptgx-20241231xex19d1002.jpg GRAPHIC 818
18 GRAPHIC ptgx-20241231xex19d1003.jpg GRAPHIC 17868
  Complete submission text file 0001558370-25-001317.txt   13189815

Data Files

Seq Description Document Type Size
19 EX-101.SCH ptgx-20241231.xsd EX-101.SCH 72832
20 EX-101.CAL ptgx-20241231_cal.xml EX-101.CAL 81408
21 EX-101.DEF ptgx-20241231_def.xml EX-101.DEF 279936
22 EX-101.LAB ptgx-20241231_lab.xml EX-101.LAB 586455
23 EX-101.PRE ptgx-20241231_pre.xml EX-101.PRE 512183
110 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20241231x10k_htm.xml XML 1994626
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37852 | Film No.: 25652528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)